Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants

(2011) Joan S. Ko et al.   BJU INTERNATIONAL

Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer

(2011) Giorgio Guazzoni et al.   EUROPEAN UROLOGY

Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators

(2011) Monique J. Roobol et al.   EUROPEAN UROLOGY

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys145 or Lys146 from fPSA without internal cleavages at Lys145 or Lys146

(2011) Mari T. Peltola et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Complications After Prostate Biopsy: Data From SEER-Medicare

(2011) Stacy Loeb et al.   JOURNAL OF UROLOGY

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

(2011) Monique J. Roobol et al.   WORLD JOURNAL OF UROLOGY

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum

(2010) Axel Semjonow et al.   CLINICAL BIOCHEMISTRY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication

(2010) Andrew Vickers et al.   JOURNAL OF CLINICAL ONCOLOGY

Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy

(2010) Robert K. Nam et al.   JOURNAL OF UROLOGY

[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study

(2010) Brian V. Le et al.   JOURNAL OF UROLOGY

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

(2008) Andrew J Vickers et al.   BMC Medicine